Clin2
NCT06748404Possibly a fitRecruiting

TriCalm Hydrogel for Itching from Immunotherapy

Immunotherapy-related Pruritus

Part of Skin clinical trials.

This trial tests a gel called TriCalm Hydrogel to see if it helps reduce itching caused by immunotherapy cancer treatment. If you have itching from your immunotherapy, this study might offer relief.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
28 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You are getting immunotherapy for cancer at UC San Diego's Moores Cancer Center.
  • You have developed mild to moderate itching after at least one dose of immunotherapy.
  • You do not have a skin condition like eczema or psoriasis that causes itching.
  • You have not started new anti-itch pills or creams in the last 7 days.
  • Your itching is not on your face.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06931119Not yet recruiting· Phase 1
Medication for itching caused by immunotherapy

This trial tests if the drug Aprepitant can help relieve itching caused by immunotherapy treatments in people with solid tumors. It is for those whose itching has not responded to standard treatments or started after beginning immunotherapy.

NCT05689463Recruiting
Testing antibodies in itching after immune therapy

This study checks blood antibodies (BP180 and BP230) in people who develop long-lasting itching after starting immune therapy for cancer. It may help doctors understand why the itching happens and how it relates to autoimmune skin conditions.

Rouen
NCT07580911Not yet recruiting
Fast-Acting Gel for Severe Itching Relief

This trial tests a gel containing hyaluronic acid (a natural skin moisturizer) to quickly relieve moderate-to-severe itching from conditions like eczema, bug bites, or hives. The study measures how well it works and how safe it is.

NCT06226610Recruiting· Phase 2
Testing dupilumab for severe itching after burn injuries

This trial tests if dupilumab (Dupixent) can help adults with long-lasting, severe itching from healed burn scars. It is for people whose itching has not improved with standard treatments like antihistamines.

Akron, Ohio
NCT07598383Recruiting· Phase 2
Gel treatment for mild-to-moderate atopic dermatitis

This study tests a new gel called VC005 to see if it safely reduces itching, redness, and irritation in people with atopic dermatitis (a chronic skin condition). You'll be randomly assigned to either the new gel or a placebo (inactive gel) and apply it to affected areas over several weeks.

Hangzhou, Zhejiang
NCT06771375Not yet recruiting
EMDR therapy for long-term itching

This study tests whether a psychological therapy called EMDR (which uses eye movements to process difficult memories) can help reduce chronic itching. You may be able to join if you have had moderate to severe itching for a long time and are not on certain other treatments.

Basel

Hear when a new Immunotherapy-related Pruritus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.